Sachs European Life Sciences CEO Forum

Accelerating Cancer Immunotherapy Research (ACIR) has featured Immunetune's presentation during the Cancer Immunotherapy (CIMT) Annual Meeting 2022 held May 10-12 in Mainz, Germany. At CIMT, our CSO Jeroen van Bergen presented new preclinical results on our neoantigen...

Immunetune and Daicel Initiate Research Collaboration on Vaccine Injection Device   LEIDEN, the Netherlands; OSAKA, Japan; April 22, 2022 -- Immunetune, a preclinical-stage biotech developing next-generation DNA vaccines against cancer and infectious diseases,...